BeyondSpring Inc. Operating Lease, Expense
BeyondSpring Inc. (BYSI) reported Operating Lease, Expense of $281.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-25
- BeyondSpring Inc. operating lease, expense for the quarter ending 2019-12-31 was $221.00K, a 4.74% decline year-over-year.
- BeyondSpring Inc. operating lease, expense for the quarter ending 2019-09-30 was $198.00K, a 86.79% increase year-over-year.
- BeyondSpring Inc. operating lease, expense for the quarter ending 2019-06-30 was $195.00K, a 37.32% increase year-over-year.
- BeyondSpring Inc. operating lease, expense for the quarter ending 2019-03-31 was $202.00K, a 197.06% increase year-over-year.
- BeyondSpring Inc. operating lease, expense for fiscal 2025 was $281.00K, a 5.24% increase from fiscal 2024.
- BeyondSpring Inc. operating lease, expense for fiscal 2024 was $267.00K, a 61.64% decline from fiscal 2023.
- BeyondSpring Inc. operating lease, expense for fiscal 2023 was $696.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $281.00K 10-K · filed 2026-03-25 | |||
| 2024-12-31 | $267.00K 10-K · filed 2026-03-25 | |||
| 2023-12-31 | $696.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $1.11M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $725.00K 20-F · filed 2023-04-18 | |||
| 2020-12-31 | $878.00K 20-F · filed 2023-04-18 | |||
| 2019-12-31 | $221.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $419.00K derived: sum of 2 quarters · filed 2022-04-14 | $614.00K derived: sum of 3 quarters · filed 2022-04-14 | $816.00K 20-F · filed 2022-04-14 |
| 2019-09-30 | $198.00K 6-K · filed 2019-12-18 | $393.00K derived: sum of 2 quarters · filed 2019-12-18 | $595.00K 6-K · filed 2019-12-18 | $827.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-06-30 | $195.00K 6-K · filed 2019-09-18 | $397.00K 6-K · filed 2019-09-18 | $629.00K derived: sum of 3 quarters · filed 2021-04-30 | $735.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-03-31 | $202.00K 6-K · filed 2019-07-10 | $434.00K derived: sum of 2 quarters · filed 2021-04-30 | $540.00K derived: sum of 3 quarters · filed 2021-04-30 | $682.00K derived: sum of 4 quarters · filed 2021-04-30 |
| 2018-12-31 | $232.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $338.00K derived: sum of 2 quarters · filed 2021-04-30 | $480.00K derived: sum of 3 quarters · filed 2021-04-30 | $548.00K 20-F · filed 2021-04-30 |
| 2018-09-30 | $106.00K 6-K · filed 2019-12-18 | $248.00K derived: sum of 2 quarters · filed 2019-12-18 | $316.00K 6-K · filed 2019-12-18 | |
| 2018-06-30 | $142.00K 6-K · filed 2019-09-18 | $210.00K 6-K · filed 2019-09-18 | ||
| 2018-03-31 | $68.00K 6-K · filed 2019-07-10 | |||
| 2017-12-31 | $200.00K 20-F · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |